{"id":354416,"date":"2026-02-19T00:01:00","date_gmt":"2026-02-19T06:01:00","guid":{"rendered":"https:\/\/www.mgsmfg.com\/?p=354416"},"modified":"2026-02-18T12:55:47","modified_gmt":"2026-02-18T18:55:47","slug":"mgs-opens-new-wisconsin-facility-to-advance-drug-delivery-device-manufacturing-in-the-u-s","status":"publish","type":"post","link":"https:\/\/www.mgsmfg.com\/es\/press-releases\/mgs-opens-new-wisconsin-facility-to-advance-drug-delivery-device-manufacturing-in-the-u-s\/","title":{"rendered":"MGS Opens New Wisconsin Facility to Advance Drug Delivery Device Manufacturing in the U.S."},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.16″ global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.16″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.5″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n

300,000-square-foot facility adds 300 jobs and expands domestic production to support Pharmaceutical device innovation.<\/em><\/p>\n

RICHFIELD, Wis. (February 19, 2026)<\/strong> \u2013MGS<\/a>, a leading healthcare contract development and manufacturing organization (CDMO), is proud to introduce its newest world-class manufacturing facility in Richfield, Wisconsin. A major milestone in its ongoing mission to accelerate innovations that improve lives, this 300,000-square-foot state-of-the-art operation was developed to support a global Pharmaceutical partner\u2019s growing drug delivery platform.<\/span><\/p>\n

Central to the site\u2019s advanced capabilities is 140,000-square-feet of Class 8 cleanrooms designed for high-performance manufacturing, automation and assembly of complex Pharma drug delivery devices. Built to meet growing demand for faster scale-up and high-volume manufacturing, the site exemplifies how vertical integration and close customer alignment accelerate development.<\/p>\n

In just 22 months from initial conversations to shipped parts, MGS transformed vision into reality. The result is a highly automated environment capable of producing hundreds of millions of sub-assemblies each year. Phase one of the build includes more than 100 injection molding machines, custom automation technology and high-efficiency automated assembly lines, engineered for scalability, quality and precision. Phase two builds on that foundation, doubling production capacity to support long-term product line growth.<\/p>\n

\u201cFrom day one, every decision was guided by our customer\u2019s needs and the patients they serve,\u201d said Bob Bordignon, senior vice president of sales & marketing at MGS. \u201cThis facility is proof of what\u2019s possible when aligned expertise and a shared vision come together to accelerate life-changing therapies. Our agile structure and financial strength enabled the speed, investment and coordination required to bring this complex project to life on an ambitious timeline.\u201d<\/p>\n

The Richfield expansion brings MGS\u2019 global footprint to 12 facilities, advancing its position as a vertically integrated partner to leading healthcare innovators. With capabilities spanning early-stage design and development, advanced tooling, custom automation, precision medical manufacturing and assembly, MGS serves as a single source across North America and Europe. These end-to-end services are reinforced by deep regulatory expertise and a highly skilled team, ensuring speed, compliance and confidence throughout the product lifecycle.<\/p>\n

Building a Specialized Workforce for Advanced Pharmaceutical Device Manufacturing<\/strong><\/p>\n

The Richfield facility marks a strategic investment in both infrastructure and talent, and a significant boost for the local economy. The site will create 300 new jobs across engineering, production, automation, quality and mold maintenance, expanding access to high-quality careers in advanced manufacturing. Newly created roles will be open to both skilled professionals and those new to the industry, with full staffing anticipated by early 2027.\u00a0<\/p>\n

\u201cMGS Richfield represents more than a new facility. It\u2019s about people, innovation and long-term impact,\u201d said Monica MacDonald, senior vice president of human resources at MGS. \u201cWe\u2019re proud to support Richfield and the surrounding community by creating hundreds of jobs for seasoned manufacturers and those just starting their careers. This investment reflects our commitment to developing local talent, advancing critical technologies and creating strong career pathways that offer growth and opportunity in the communities we operate.\u201d<\/p>\n

In-demand roles include:<\/p>\n